These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 34663879)
1. Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. Yan H; Yu CC; Fine SA; Youssof AL; Yang YR; Yan J; Karg DC; Cheung EC; Friedman RA; Ying H; Chen EI; Luo J; Miao Y; Qiu W; Su GH Oncogene; 2021 Dec; 40(50):6759-6771. PubMed ID: 34663879 [TBL] [Abstract][Full Text] [Related]
2. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer. Zhou H; Qin Y; Ji S; Ling J; Fu J; Zhuang Z; Fan X; Song L; Yu X; Chiao PJ Oncogene; 2018 Feb; 37(7):912-923. PubMed ID: 29059173 [TBL] [Abstract][Full Text] [Related]
3. LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma. Huang S; Li Y; Hu J; Li L; Liu Z; Guo H; Jiang B; Chen J; Li J; Xiang X; Deng J; Xiong J J Cell Mol Med; 2021 May; 25(9):4275-4286. PubMed ID: 33834618 [TBL] [Abstract][Full Text] [Related]
4. A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma. Ben Q; An W; Sun Y; Qian A; Liu J; Zou D; Yuan Y J Exp Clin Cancer Res; 2020 Sep; 39(1):181. PubMed ID: 32894161 [TBL] [Abstract][Full Text] [Related]
5. PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells. Liang C; Shi S; Liu M; Qin Y; Meng Q; Hua J; Ji S; Zhang Y; Yang J; Xu J; Ni Q; Li M; Yu X Cancer Res; 2019 Jan; 79(1):133-145. PubMed ID: 30355620 [TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity for Kras Ma Y; Li Y; Ling S; Li X; Kong B; Hu M; Huang P Biochem Biophys Res Commun; 2020 Jun; 526(4):880-888. PubMed ID: 32279996 [TBL] [Abstract][Full Text] [Related]
8. Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo. Qiu W; Sahin F; Iacobuzio-Donahue CA; Garcia-Carracedo D; Wang WM; Kuo CY; Chen D; Arking DE; Lowy AM; Hruban RH; Remotti HE; Su GH Oncotarget; 2011 Nov; 2(11):862-73. PubMed ID: 22113502 [TBL] [Abstract][Full Text] [Related]
9. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells. Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203 [TBL] [Abstract][Full Text] [Related]
10. Loss of Heterozygosity for Ma Y; Ling S; Li Y; Hu M; Kong B; Huang P; Liu H Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743139 [TBL] [Abstract][Full Text] [Related]
11. Crosstalk between hypoxia-sensing ULK1/2 and YAP-driven glycolysis fuels pancreatic ductal adenocarcinoma development. Jia Y; Li HY; Wang Y; Wang J; Zhu JW; Wei YY; Lou L; Chen X; Mo SJ Int J Biol Sci; 2021; 17(11):2772-2794. PubMed ID: 34345207 [TBL] [Abstract][Full Text] [Related]
12. The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling. Maity G; Haque I; Ghosh A; Dhar G; Gupta V; Sarkar S; Azeem I; McGregor D; Choudhary A; Campbell DR; Kambhampati S; Banerjee SK; Banerjee S J Biol Chem; 2018 Mar; 293(12):4334-4349. PubMed ID: 29414775 [TBL] [Abstract][Full Text] [Related]
13. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia. McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621 [TBL] [Abstract][Full Text] [Related]
15. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Hu T; Shukla SK; Vernucci E; He C; Wang D; King RJ; Jha K; Siddhanta K; Mullen NJ; Attri KS; Murthy D; Chaika NV; Thakur R; Mulder SE; Pacheco CG; Fu X; High RR; Yu F; Lazenby A; Steegborn C; Lan P; Mehla K; Rotili D; Chaudhary S; Valente S; Tafani M; Mai A; Auwerx J; Verdin E; Tuveson D; Singh PK Gastroenterology; 2021 Nov; 161(5):1584-1600. PubMed ID: 34245764 [TBL] [Abstract][Full Text] [Related]
16. Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer. Weng CC; Hsieh MJ; Wu CC; Lin YC; Shan YS; Hung WC; Chen LT; Cheng KH Mol Cancer; 2019 May; 18(1):96. PubMed ID: 31109321 [TBL] [Abstract][Full Text] [Related]
17. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression. Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123 [TBL] [Abstract][Full Text] [Related]
18. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2. Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517 [TBL] [Abstract][Full Text] [Related]
20. PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-Catenin Gao C; Chen G; Zhang DH; Zhang J; Kuan SF; Hu W; Esni F; Gao X; Guan JL; Chu E; Hu J Cell Mol Gastroenterol Hepatol; 2019; 8(4):561-578. PubMed ID: 31330317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]